Top Markets
Coin of the day
Mithra Pharmaceuticals S.A. Mithra Pharmaceuticals S.A.

Mithra Pharmaceuticals S.A.

MITRA
Rank in Stocks #30361
Mithra Pharmaceuticals SA, established in 1999 and headquartered in Liège,... Mithra Pharmaceuticals SA, established in 1999 and headquartered in Liège, Belgium, specializes in the creation, production, and worldwide commercialization of advanced therapeutic solutions. The company's core focus areas include contraception, the management of menopause, and treatments for hormone-dependent cancers. Its robust development pipeline features Estelle, a combined oral contraceptive that has successfully concluded Phase III clinical trials, and Donesta, an estetrol-based oral hormone treatment currently undergoing Phase III development for menopausal symptoms. Mithra's product portfolio also encompasses Myring, a hormonal contraceptive vaginal ring; Tibelia, a therapy designed to address both menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant targeting prostate and breast cancers, as well as various benign gynecological conditions. Furthermore, the company markets NEXTSTELLIS, an established oral contraceptive pill. Their offerings span diverse pharmaceutical formats, including polymeric devices, implants, sterile injectable medications, and hormonal tablets.
Share Price
$0.25620952
Last synced: 2024-07-23
Market Cap
$17.14M
Change (1 day)
10.83%
Change (1 year)
0.00%
Country
BE
Trade Mithra Pharmaceuticals S.A. (MITRA)

Category

Stock price history for Mithra Pharmaceuticals S.A. (MITRA)
Highest end of day price: $0.26 on 2024-07-01

Lowest end of day price: $13.31 on 2015-06-01
Stock price history of Mithra Pharmaceuticals S.A. from 2015 to 2026
Annual Stock Price Performance
Year Performance
2024 -79.92%
2023 -68.31%
2022 -82.82%
2021 -7.44%
2020 -13.95%
2019 18.19%
2018 100.30%
2017 32.01%
2016 -15.12%
2015 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$162.21 25.48%
DE
$37.44 22.48%
JP
$220.57 31.75%
CH
$20.69 10.80%
IN